BCAX Competitors & Alternatives

Compare Bicara Therapeutics Inc. Common Stock with similar stocks in the same industry

Biotechnology

BCAX

Main Stock
$9.58
-4.39%
Tradestie Score
52
Market Cap
$906.29M
Analyst Upside
+235.8%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: bifunctional antibodies, tumor-targeted immunotherapy
Major Customers 2
oncology treatment centers cancer patients
Critical Suppliers 2
CROs biomanufacturing partners
Direct Ecosystem Rivals 3

Top Competitors

217 stocks in Biotechnology
Company Price Market Cap P/E Score Action
TBPH Theravance Biopharma, Inc.
$17.03
$726.21M 16.4 51 Compare
NRIX Nurix Therapeutics, Inc. Common stock
$14.87
-3.94%
$718.62M 6.4 52 Compare
TYRA Tyra Biosciences, Inc. Common Stock
$20.18
+0.77%
$715.25M - 31 Compare
DAWN Day One Biopharmaceuticals, Inc. Common Stock
$21.53
+0.19%
$704.73M - 51 Compare
PVLA Palvella Therapeutics, Inc. Common Stock
$144.37
-5.32%
$699.30M - 49 Compare
TERN Terns Pharmaceuticals, Inc. Common Stock
$52.95
+0.04%
$683.46M - 49 Compare
ANL ANL
$9.87
-6.97%
$677.47M - 48 Compare
MGTX MeiraGTx Holdings plc Ordinary Shares
$8.83
-3.87%
$665.30M 10.1 46 Compare
ERAS Erasca, Inc. Common Stock
$15.16
-3.22%
$626.91M - 35 Compare
SVRA Savara Inc.
$4.45
-4.20%
$611.84M - 56 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)

217 stocks in this industry